Correlation Between Intestinal Microflora Metabolites and Amyotrophic Lateral Sclerosis
NCT04948346 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2021-07-01
Summary
To verify the correlation between TMAO level and the pathogenesis and progression of ALS
Conditions
Interventions
- OTHER
-
diagnosed with ALS
diagnosed with ALS
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Lu Chen · Peking University Third Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-31
- Primary Completion
- 2020-12-31
- Completion
- 2021-06-01
Countries
- China
Study Locations
More Related Trials
-
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis
NCT04455542 ·Status: COMPLETED
-
Intestinal Microbiome Transplant in ALS
NCT07017946 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
NCT06771414 ·Status: NOT_YET_RECRUITING
-
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
NCT06391645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Registered Cohort Study on Amyotrophic Lateral Sclerosis
NCT04008329 ·Status: RECRUITING
-
Mitochondrial Functions and Oxidative Stress in ALS Patients
NCT00331812 ·Status: UNKNOWN
-
Neuromuscular Magnetic Stimulation in ALS Patients
NCT03618966 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients
NCT03766321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis
NCT05889572 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis
NCT06181526 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Determinants of Disease Severity in Amyotrophic Lateral Sclerosis
NCT00004457 ·Status: UNKNOWN
-
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
NCT06493279 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related Diseases
NCT04956822 ·Status: UNKNOWN
-
Amyotrophic Lateral Sclerosis Registry
NCT05892822 ·Status: UNKNOWN
-
Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
NCT01492686 ·Status: COMPLETED ·Phase: PHASE3
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Muscular Biomarkers in Amyotrophic Lateral Sclerosis
NCT02670226 ·Status: COMPLETED ·Phase: NA
-
Amyotrophic Lateral Sclerosis and the Innate Immune System
NCT02869048 ·Status: RECRUITING
-
Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00424463 ·Status: COMPLETED ·Phase: PHASE3
-
A Longitudinal Analysis of Biomarkers in Patients With ALS
NCT05309408 ·Status: UNKNOWN
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00445172 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical Procedures to Support Research in ALS
NCT03489278 ·Status: RECRUITING
-
A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00444613 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intermuscular Coherence as a Biomarker for ALS
NCT05104710 ·Status: RECRUITING